Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic CV disease, …
Copyright MatchingDonors.com © 2026 All rights reserved.
Daily Diabetes News is published by MatchingDonors.com.